September 30 COVID-19 Conference Participants
Chil-Yong Kang

Professor, Ph. D., MD, FRSC, is a molecular virologist and Professor of Virology at the faculty of Microbiology and immunology of the school of medicine and dentistry. Schulich University of Western Ontario in Canada.His research in molecular Virology includes the development of virus-specific antiviral therapeutic agents and effective vaccines against various human viral diseases, including AIDS, hepatitis, and hemorrhagic fever with renal syndrome. It has already developed a second-generation vaccine against the hepatitis B virus and an experimental HIV / AIDS vaccine using state-of-the-art genetic engineering and biotechnology technologies.